Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness

J Alzheimers Dis. 2017;60(3):1161-1170. doi: 10.3233/JAD-170348.

Abstract

Neuropsychiatric symptoms in Alzheimer's disease are among the most disabling and difficult aspects for caregivers and treating health professionals to manage. Despite the high prevalence of these behaviors, little is known about the factors which lead some patients to develop florid behavioral symptoms while others may progress to severe dementia without such phenomenon. We examined whether regional brain volumes as measured by cortical thickness would predict the presence or absence of disinhibition in patients with Alzheimer's disease. Using data from the ADNI, we identified 758 patients with caregiver ratings on the Neuropsychiatric Inventory and a volumetric MRI scan with cortical thickness measurements completed in FreeSurfer by the UCSF core. Of these, 177 patients were found to have disinhibition. Logistic regression models demonstrated that reduced cortical thickness in the right frontal pole was associated with the presence of disinhibition even when controlling for age, disease severity, total intracranial volume, gender, and APOE genotype. The results are considered in the context of leading models of the functions of frontopolar cortex.

Keywords: Alzheimer’s disease; disinhibition; frontopolar cortex.

MeSH terms

  • Aged
  • Alzheimer Disease / diagnostic imaging*
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology
  • Alzheimer Disease / psychology*
  • Apolipoproteins E / genetics
  • Cohort Studies
  • Female
  • Frontal Lobe / diagnostic imaging*
  • Frontal Lobe / pathology
  • Functional Laterality
  • Humans
  • Image Processing, Computer-Assisted
  • Inhibition, Psychological
  • Logistic Models
  • Magnetic Resonance Imaging
  • Male
  • Neuropsychological Tests
  • Organ Size
  • Sex Factors

Substances

  • Apolipoproteins E